Heart and Lung Complications: Assessment and prevention of venous thromboembolism and cardiovascular disease in patients with multiple myeloma

    loading  Checking for direct PDF access through Ovid

Abstract

BACKGROUND:

Venous thromboembolism (VTE) and cardiovascular (CV) disease can occur in patients with multiple myeloma. Although VTE and CV disease are separate medical conditions, they can be serious and even life-threatening.

OBJECTIVES:

The objectives of this article are to describe risk factors for cancer-associated VTE, describe the influence of CV disease on patients with multiple myeloma, and review the approaches to VTE and CV disease identification and treatment.

METHODS:

PubMed and CINAHL® databases were used to identify literature to describe VTE and CV in patients diagnosed with multiple myeloma.

FINDINGS:

When present in patients with multiple myeloma, VTE and CV disease can limit patient tolerance for myeloma treatment and, therefore, decrease therapeutic options.

Related Topics

    loading  Loading Related Articles